Serum binding folate receptor autoantibodies lower in autistic boys and positively-correlated with folate

Ai Shi,Di Liu,Huiwen Wu,Rui Zhu,Ying Deng,Lulu Yao,Yaqian Xiao,George H. Lorimer,Reza A. Ghiladi,Xinjie Xu,Rong Zhang,Haiqing Xu,Jun Wang
DOI: https://doi.org/10.1016/j.biopha.2024.116191
IF: 7.419
2024-02-06
Biomedicine & Pharmacotherapy
Abstract:Folate receptor autoantibody (FRAA) has caught increasing attention since its discovery in biological fluids of patients with autism spectrum disorder (ASD), but quantification and understanding of its function are still in their infancy. In this study, we aimed to quantify serum binding-FRAA and explore its relation with serum folate, vitamin B 12 (VB 12 ) and ferritin. We quantitated serum binding-FRAA in 132 ASD children and 132 typically-developing (TD) children, as well as serum levels of folate, VB 12 and ferritin. The results showed that serum binding-FRAA in the ASD group was significantly lower than that in the TD group (p 0.05). However, there was significant difference in boys between these two groups, not girls. Additionally, the combination of nitrite and binding-FRAA showed potential diagnostic value in patients with ASD (AUC > 0.7). Moreover, in the ASD group, the level of folate was consistent with that of binding-FRAA, whereas in the TD group, the binding-FRAA level was high when the folate level was low. Altogether, these differences revealed that the low serum FRAA in autistic children was mediated by multiple factors, which deserves more comprehensive investigation with larger population and mechanistic studies.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?